NRC Workshop Organizing Committee
Mahmoud, Adel (Chair)
Princeton University, United States
Adel A. F. Mahmoud (M.D., Ph.D.) is at the Woodrow Wilson School of Public and International Affairs and the Department of Molecular Biology at Princeton University. He recently retired as president of Merck Vaccines and a member of the management committee of Merck & Company, Inc. His prior academic services at Case Western Reserve University and University Hospitals of Cleveland spanned 25 years concluding as chairman of medicine and physician-in-chief from 1987 to 1998. Dr. Mahmoud’s academic pursuits focused on investigations of the determinants of infection and disease in human schistosomiasis and other infectious agents. In laboratory and field studies in several endemic areas, he developed the scientific bases of strategies to control helminthic infections, which have been adopted globally. At Merck, Dr. Mahmoud led the effort to develop four new vaccines: combination of measles, mumps, rubella and varicella; rota virus; shingles; and human papillomavirus. He is an active contributor to scientific literature and authored and edited several textbooks and reports. Dr. Mahmoud received his M.D. degree from the University of Cairo in 1963 and his Ph.D. from the University of London, School of Hygiene and Tropical Medicine in 1971. He was elected to membership of the American Society for Clinical Investigation in 1978, the Association of American Physicians in 1980, and the Institute of Medicine of the National Academy of Sciences in 1987. Dr. Mahmoud is a fellow of the American College of Physicians and a member of the Expert Advisory Panel on Parasitic Diseases of the World Health Organization. He served on the National Advisory Allergy and Infectious Diseases Council and is a past president of the Central Society for Clinical Research and the International Society for Infectious Diseases. He is currently serving as a member of the National Science Advisory Board for Biosecurity and the Committee on Scientific Communications and National Security (CSCANS) of the National Academy of Sciences.
DARPA, United States
Dr. Callahan has extensive knowledge of biological laboratories in Africa and Asia. He has directed multiple USAID and World Bank-funded projects in Africa and Asia and served as program manager and emergency clinical consult physician for a United States Department of State non-proliferation and biological threat reduction and redirection effort in former biological weapons facilities in Russia. His research interests are in the area of new technology and novel drug development to address catastrophic health events. He received undergraduate degrees from the University of Massachusetts, Amherst in microbiology and environmental toxicology. He received a M.P.H. and a M.D. from the University of Alabama, and he received his tropical medicine training from the London School of Tropical Medicine and Hygiene. Dr. Callahan has been active in disaster medicine, wilderness medicine, and medical care in resource-constrained regions since 1982. In 1988, he co-founded the charter organization Rescue Medicine, which provides emergency air medical evacuation and refugee medical care in austere developing regions. Following the events of 9/11, Dr. Callahan served as director of biodefense and mass-casualty care at the Center for Integration of Medicine and Innovative Technology, a multi-institution rapid medical research consortium, and as staff physician at Massachusetts General Hospital in Boston. His current activities include active clinical consultation for highly dangerous pathogens and envenomation and active duty as command physician for Rescue Medicine Airlift One’s international disaster medicine team. He began working with the Defense Advanced Research Projects Agency
(DARPA) in 2005 and was recognized with the DARPA 2008 Achievement Award for his work on emergency and pandemic influenza vaccine manufacture.
Asia-Pacific Biosafety Association, Malaysia
Dr. Chua has experience working for the World Health Organization and the Food and Agriculture Organization of the United Nations on laboratory capacity building in the Asia-Pacific region. Additionally, he serves as a laboratory consultant for the Temasek Life Science Laboratory of the National University of Singapore. He is the current treasurer and past president of the Asia-Pacific Biosafety Association.
MRIGlobal, United States
David R. Franz is vice president and chief biological scientist at MRIGlobal and senior advisor to the Office of the Assistant to the Secretary of Defense for Nuclear, Chemical and Biological Defense Programs. Dr. Franz served in the United States Army Medical Research and Materiel Command for 23 of 27 years on active duty and retired as a colonel. He served as commander of the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and as deputy commander of the Medical Research and Materiel Command. Prior to joining the Command, he served as group veterinarian for the 10th Special Forces Group (Airborne). Dr. Franz was technical editor for the Textbook of Military Medicine on Medical Aspects of Chemical and Biological Warfare released in 1997. He serves on numerous national committees and boards. Dr. Franz holds an adjunct appointment as professor for the Department of Diagnostic Medicine and Pathobiology at the College of Veterinary Medicine, Kansas State University. The current focus of his activities relates to the role of international engagement in the life sciences as a component of national security policy. Dr. Franz holds a D.V.M. from Kansas State University and a Ph.D. in physiology from Baylor College of Medicine.
Rebuild Japan Initiative
Katsuhisa Furukawa has been an adjunct fellow at the Rebuild Japan Initiative since July 2011. From October 2004 through August 2011, he was a fellow of the Research Institute of Science and Technology for Society (RISTEX) in the Japan Science and Technology Agency, which put him in charge of a project on science, diplomacy, and security. He has joined various Japanese government and nongovernmental study groups, including groups at the Office of National Security and Crisis Management of the Cabinet Secretariat; the Ministry of Foreign Affairs; the Ministry of Education, Science, and Technology; the Ministry of Justice; the Ground Self-Defense Force; and the Japan Aerospace Exploration Agency. He was in charge of projects on science and technology for counter-terrorism commissioned by the Ministry of Education, Science, and Technology (2006-2009). He is also a member of the Council of Asian Transnational Threat Research (October 2006-present) and a lecturer for the United Nations Security Council Resolution 1540 Committee Regional Workshop (March 2009-present).
Sandia National Laboratories, United States
Jennifer Gaudioso manages the International Biological Threat Reduction program at Sandia National Laboratories (SNL) in Albuquerque, NM, USA. This program enhances U.S. and international security by promoting safe, secure, and responsible use of dangerous biological agents. Dr. Gaudioso and her SNL team have worked extensively in laboratory biosafety, biosecurity, biocontainment, and infectious disease diagnostics and control internationally. They have organized many international conferences, trainings, and workshops on these topics. In the last five years, the team has visited biocontainment laboratories in more than 40 countries specifically to consult on laboratory biorisk management issues. She and her SNL team work with international partners, such as the World Health Organization, on the development of international laboratory biorisk guidelines and standards. She served on the National Academies’ Committee on Education on Dual Use Issues in the Life Sciences. She is author of numerous journal
articles and has presented her research at national and international meetings. She also co-authored the Laboratory Biosecurity Handbook, published by CRC Press. Dr. Daudioso serves on SNL’s Institutional Biosafety Committee and is an active member of the American Biological Safety Association. She earned her Ph.D. at Cornell University.
Biosafety Biosecurity International, United States
Dr. Barbara Johnson owns the consulting company Biosafety Biosecurity International. She is a microbiologist with over 15 years of experience in the United States government in the areas of biosafety, biocontainment, and biosecurity. Her research areas include biological risk assessment and mitigation, testing the efficiency of respiratory protective devices, and testing novel decontamination methods against biological select agents and toxins. She provides training and consultation in the United States and internationally (over 20 countries) on biosafety and biosecurity matters as they pertain to risk assessment; management and mitigation; emergency response; and BSL/ABSL -2, -3, -4 and ABSL-3 facility design, testing, audit, and construction. Her technical and policy advice and strategies are requested in the United States by various government agencies, companies, universities, and subcommittees (ANSI, Senate, National Biosafety and Biocontainment Training Program, etc.) as well as internationally by Ministries of Health. She has recently served on three National Academy of Sciences panels focused on high and maximum containment laboratories and currently serves on the NRC committee providing continuing assistance to the National Institutes of Health on preparation of additional risk assessments for the Boston University National Emerging Infectious Diseases Laboratory. Dr. Johnson is a Registered Biosafety Professional, approved BSL-3 Facility Certifier and Trainer by the Singapore Ministry of Health, past president of ABSA, past vice president of A-PBA, founding member of IFBA, and co-editor of the peer-reviewed journal Applied Biosafety.
Swedish Institute for Communicable Disease Control
Dr. Kallings is a senior medical officer and biosafety advisor for the Swedish Institute for Infectious Disease Control (SMI). Ingegerd Kallings has a medical degree from Karolinska Institutet, with a specialization in clinical bacteriology. She was head of the WHO Collaborating Center on Legionella Infections at SMI. From 1997 until 2004, she was senior medical officer and biosafety officer at SMI, during which time SMI constructed and made operational PCL 3 and 4 laboratories including PCL 3 animal facilities for non-human primates. From 1996 to 2009, she was the head of the WHO Collaborating Centre on Biological Safety at SMI and a member of the WHO Biosafety Advisory Group. She recently coordinated a Swedish government-funded project with China’s CDC: Advanced Biosafety Capacity Building in the Chinese National System for Infectious Disease Control and Prevention. Dr. Kallings was a council member of the European Biosafety Association (EBSA) 2005-06, EBSA president in 2009-10, and an EBSA honorary member from 2001. She founded the Nordic Network for Biosafety in 2004 and since 2009 has been a member of BioRisk Information, Communication, Knowledge and Scientific Advice at the European Centre for Disease Prevention and Control. Dr. Kallings was a temporary advisor and short-term consultant to the WHO on various topics including WHO polio eradication and influenza (avian flu) programs. Her experience with developing countries includes Vietnam (research collaboration on antibiotic resistance surveillance), Russian Federation (surveillance of sexually transmitted diseases for the World Bank, biosafety and biosecurity projects, and establishment of an infection control and laboratory network), and the Baltic Sea States (Council of Baltic Sea States Task Force to Combat Communicable Diseases). She has published and lectured on sexually transmitted diseases, legionella infections, antibiotic resistance control, and biosafety.
Palladin Institute of Biochemistry, Ukraine
Serhiy Komisarenko is currently the academician-secretary of the Division of Biochemistry, Physiology and Molecular Biology of the National Academy of Sciences of Ukraine (since 2004), the director of the Palladin Institute of Biochemistry (1989-1992 and since 1998) and the head of the Laboratory of
Molecular Immunology at Palladin Institute of Biochemistry (1982-1989 and since 1998). He is also the chairman of the Commission on Biosafety and Biosecurity at the National Security and Defense Council of Ukraine (since 2007). Dr. Komisarenko was formerly the ambassador of Ukraine to the United Kingdom (1992-1998), ambassador of Ukraine to Ireland (simultaneously, 1995-1998); deputy prime minister of Ukraine responsible for the humanitarian sector (1990-1992); the head of the Laboratory of Immunochemistry (1975-1982); scientific secretary of the Institute (1972-1974); as well as a junior scientific researcher in the Institute of Biochemistry of the Ukrainian Academy of Sciences, Kyiv (1969-1972). Dr. Komisarenko has been an invited lecturer at many institutions. Dr. Komisarenko is a Doctor of Medicine with distinction (1966, Kyiv Medical Institute) and holds a Ph.D. in biochemistry (1970). He did his post-graduate course in biochemistry in the Institute of Biochemistry of the Ukrainian Academy of Sciences (1966-1969) and completed courses on advanced immunology at the Pasteur Institute in Paris (1974-1975). Since 1992, he has had the life title of Ambassador of Ukraine. Dr. Komisarenko is the editor-in-chief of the Ukrainian Biochemical Journal (1989-1992 and since 1998) and Biotechnology (Ukraine) (2008-). He is also the president of the Ukrainian Biochemical Society (1999-).
Le Duc, James
University of Texas Medical Branch, United States
Jim Le Duc, Ph.D. is the director of the Galveston National Laboratory (GNL) located on the campus of the University of Texas Medical Branch (UTMB) in Galveston, Texas and holds the inaugural Robert E. Shope, M.D. and John S. Dunn Distinguished Chair in Global Health. Dr. Le Duc joined UTMB in late 2006 from the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, where he held various positions including influenza coordinator (2005-2006), director of the Division of Viral and Rickettsial Diseases (2000-2005), and associate director for the Center for Global Health (1996-2000). He was a medical officer in charge of arboviruses and viral hemorrhagic fevers at the World Health Organization in Geneva, Switzerland (1992-1996) and he held leadership positions during a 23-year career as a United States Army officer in the medical research and development command, with assignments in Brazil, Panama, and at various locations in the United States, including the Walter Reed Army Institute of Research and the United States Army Medical Research Institute of Infectious Diseases. He is a member of various professional organizations, has published over 200 scientific articles and book chapters, and is well recognized as an expert in viral diseases, biodefense, and global health. Dr. Le Duc earned his M.S.P.H. and Ph.D. degrees from the University of California at Los Angeles.
Ministerial Standing Committee on Scientific and Technological Cooperation (COMSTECH), Pakistan
Dr. Anwar Nasim is a renowned name in the field of science in Pakistan. He currently works as a science adviser for COMSTECH. Dr. Nasim has been actively involved in the socio-economic development of Pakistan and of other Islamic countries. His main areas of interest are molecular biology, biotechnology and genetic engineering. Dr. Nasim has over 100 scientific publications in prestigious international journals. He is an author of eight books and is a member of the editorial boards of six science magazines. He was an international coordinator and member of the Executive Committee for the XVI International Congress of Genetics, Toronto, Canada (1988). Dr. Anwar Nasim has earned a number of awards. Starting from the Gold Medal in M.Sc. Botany, he has to his credit the Pride of Performance (molecular genetics, 1995) awarded by the president of Pakistan and Sitara-i-Imtiaz (molecular genetics, 1999). He was awarded the Overseas Pakistanis’ Institute (OPI) award for outstanding services for promotion of science in Pakistan (1995). He also received a special award during BioAsia2011 for his promotion of biotechnology in Asian countries as the founding president of the Federation of Asian Biotech Associations (FABA). He is an elected fellow of The Academy of Sciences for the Developing World (TWAS) and the Islamic World Academy of Sciences (IAS), and he is a fellow of the Pakistan Academy of Sciences (PAS). Dr. Nasim is playing a key role in bringing about sustainable development in Pakistan through the use of modern techniques in the fields of biotechnology and its allied disciplines in his capacity as the first chairman of the National Commission on Biotechnology of Pakistan.
Mount Sinai School of Medicine, United States
Dr. Palese is a professor of microbiology and chair of the Department of Microbiology at Mount Sinai School of Medicine in New York. His research includes work on the replication of RNA-containing viruses with a special emphasis on influenza viruses, which are negative-strand RNA viruses. He established the first genetic maps for influenza A, B and C viruses, identified the function of several viral genes, and defined the mechanism of neuraminidase inhibitors (which are now FDA-approved antivirals). Dr. Palese also pioneered the field of reverse genetics for negative-strand RNA viruses, which allows the introduction of site-specific mutations into the genomes of these viruses. This technique is crucial for the study of the structure/function relationships of viral genes, for investigation of viral pathogenicity, and for development and manufacture of novel vaccines. In addition, he and his colleagues used an improved version of the technique to reconstruct and study the pathogenicity of the highly virulent but extinct 1918 pandemic influenza virus. His recent work in collaboration with Garcia-Sastre revealed that most negative-strand RNA viruses possess proteins with interferon antagonist activity, enabling them to counteract the antiviral response of the infected host. Dr. Palese was elected to the National Academy of Sciences in 2000. At present he serves on the editorial board for the Proceedings of the National Academy of Sciences. He has been a corresponding member of the Austrian Academy of Sciences since 2002 and a member of the German Academy of Sciences Leopoldina since 2006. Dr. Palese was president of the Harvey Society in 2004/2005 and president of the American Society for Virology in 2005/2006. He was the recipient of the Robert Koch Prize in 2006, of the Charles C. Shepard Science Award in 2008, and of the 2010 European Virology Award.
Inspirion Biosciences, United States
Craig Reed is the founder and president of Inspirion Biosciences, a Maryland (United States) company that performs international work in support of various United States government agencies as well as for-profit and non-profit entities in the United States and abroad. As a captain in the United States Army, Dr. Reed was stationed at the United States Army Medical Research Institute of Infectious Diseases, Fort Detrick where he worked in biosafety level-2 and -3 laboratories studying the organisms that cause plague and anthrax. For the past 12 years, Dr. Reed has supported multiple scientific engagement programs funded by the Department of State, Department of Defense, the United States Centers for Disease Control and Prevention, and the Defense Research Projects Agency. During this time, he performed or supervised the performance of threat and vulnerability assessments at more than 50 different human and animal epidemiological laboratories as well as high and maximum containment biological research and production facilities throughout Russia, and six countries in Central Asia and the trans-Caucasus region. Dr. Reed has also worked with Ministers of Defense, Agriculture, and Emergency Situations to modernize laboratories in these same countries and to revise biosafety procedures to account for modern equipment and technology. Through Inspirion Biosciences, Dr. Reed has also led the development and delivery of a variety of training workshops in support of the National Biosafety and Biocontainment Training Program at the National Institutes of Health, the only federally-funded biosafety and biocontainment training fellowship of its type. Dr. Reed serves as technical advisor to the Secretariat of the International Federation of Biosafety Associations and as associate to the International Centre for Infectious Diseases (Winnipeg, Canada). Dr. Reed’s professional relationships and personal efforts in Central Asia provided the nucleus for the recent formation of the Biosafety Association of Central Asia and the Caucasus (BACAC). Additionally, Dr. Reed is an active member of multiple regional and national biosafety associations and regularly participates in their annual meetings. These associations include the biological safety associations of America (ABSA), Canada (CABS), the Asia-Pacific (APBA), Europe (EBSA), and Central Asia and the Caucasus (BACAC).
Kenya Medical Research Institute
Dr. Willy Kiprotich Tonui is a principal research officer (immunology) and health, safety, and environment coordinator at the Kenya Medical Research Institute (KEMRI) in Nairobi, Kenya. His work specializes in the safety and security of high-risk pathogens, occupational health, fire safety, environmental audits, hazardous chemicals, and laboratory risk management. Dr. Tonui is co-chair to the International Federation of Biosafety Associations (IFBA). IFBA is a forum for biosafety professionals of different nations that coordinates and develops a global biosafety agenda aimed at international harmonization, sharing of information, development of common standards, and collaboration in all aspects of biological safety. IFBA’s mission is to support and promote biosafety on a national and international level through collaboration among national and regional biosafety organizations worldwide. He is also a founding member and president of the African Biological Safety Association (AfBSA), a three-year old professional association that seeks to congregate practitioners of biological safety, promote biosafety and biosecurity as a discipline through awareness, and to facilitate the sharing of biosafety and biosecurity information in the African region. He is also a member of the American Biological Safety Association (ABSA) and the Asia Pacific Biosafety Association (APBA). Willy studied for his B.S. (biological sciences and chemistry) at Kurukshetra University (India), earned his M.S. and Ph.D. in immunology (specialty in vaccine development) from Kenyatta University (Kenya) and did his post-doctoral training at the School of Veterinary Medicine at Colorado State University, United States. Willy has a career-long history of supporting national programs, regulations, and policies in Kenya. He is a registered expert on Environmental Impact Assessment and Audit (EIA/EA) by the National Environmental Authority. In general, his work at KEMRI supports national programs in developing laws and regulations in hazardous waste management, biosafety, occupational health and safety, disaster management, quality management, and cleaner productivity enhancement. He is a member of several national committees including the Kenya Medical Laboratory Quality Assurance Advisory Body, the Kenya National Accreditation Services, and the National Biosafety Committee. He is currently the vice chairman of the National Biological and Toxins Weapons Convention Committee, which aims to implement UN 1540 in Kenya. He is an author of a laboratory safety handbook and three other books on fire safety and prevention.
Abdelghani, Ahmed Safwat
Central Public Health Laboratories, Egypt
Dr. Abdelghani is a medical microbiologist who serves as the head of the Microbiology Department of Central Public Health Laboratories, Egypt. He has previously worked in the fields of serology and the molecular diagnosis of viruses, particularly viral hepatitis, HIV, and influenza. He is also experienced in the laboratory diagnosis of tuberculosis. He has participated in many research studies including full genome sequencing of highly pathogenic avian influenza H5N1 virus in Egypt, molecular epidemiology of highly pathogenic avian influenza H5N1 Egyptian viruses, surveillance for measles and rubella infections in Egypt, surveys of the prevalence of hepatitis C virus in Egypt, and tuberculosis drug resistance surveillance.
Greek Pasteur institute
Dr. Antonios Antoniadis (M.D., Dip. Bact-Lond, Ph.D.) is a professor emeritus of the Medical School of the Aristotelian University of Thessaloniki, Greece. For 14 years he was the director of the ‘A’ Microbiology laboratory of the same school and head of the WHO Collaborating Centre for Reference and Research on Arbovirus and Hemorrhagic Fever Viruses, which he created in 1996. He is currently acting director and president of the Executive Board of the Hellenic Pasteur Institute in Athens. As a medical doctor, he specialized in medical microbiology and obtained the Diploma in Bacteriology from the London School of
Hygiene and Tropical Diseases. He also trained at the Yale Arbovirus Research Unit (Yale University, United States), at the Department of Disease Assessment of the United States Army Medical Research Institute for Infectious Diseases (Fort Detrick, United States), at the Central Public Health Laboratory in London, UK, and at the National Laboratory of Microbiology in Stockholm, Sweden. Since 1980, his research has focused on viral tropical diseases, particularly viral hemorrhagic fevers. The outcome of his research was the laboratory diagnosis of several “new” diseases in Greece leading to a rapid public health response during outbreaks and/or epidemics. In the context of this research, he has collaborated with laboratories of the Central African Republic, Senegal, Nigeria, Russia, and China. For nearly seven years, Dr. Antoniadis was a member of the Executive Board of the Hellenic Center for Diseases Control and Prevention, and he participated and participates in boards of the Greek Ministry of Health and Solidarity concerning public health issues. Since 1992, he is National Expert at the UN, Geneva, for the Biological Weapons Convention and the ad hoc meetings of experts, National Representative for Poliovirus Containment of the WHO Poliovirus Global Eradication Program, and during the Athens 2004 Olympic Games he coordinated the laboratory network against bioterrorism. As a WHO consultant, he lead WHO missions in Iraq during a Crimean-Congo hemorrhagic fever epidemic, he participated as an expert in boards of the European Union for issues concerning viral hemorrhagic fevers, he participated in EU missions to Russia and China, and he coordinated the EU workshop in Xian, China for the collaboration of EU and China in the field of viral hemorrhagic fevers.
Health Protection Agency, U.K.
Allan Bennett is a general project manager of biosafety at the Health Protection Agency at Porton Down in the United Kingdom. His professional background includes heading a research group of 10 scientists undertaking research in the fields of aerobiology, biocontainment, infection transmission, and bioresponse. He also was the coordinator of the European Centres for Disease Control and Prevention Biorisk Expert Group (2009-present) and worked as a package manger on the FP7 project “European Research Infrastructure on Highly Pathogenic Agents” on a package titled “Design considerations and estimating construction costs for new BSL-4 areas.” Dr. Bennett has 20 years of experience in the study of the behavior of airborne microorganisms, biocontainment design, and validation of containment systems. He led research projects for the European Space Agency in planetary protection and was a council member of the European Biosafety Association (2005-2007). He also led environmental microbiology response teams for fatal anthrax cases in Scotland and England. He has over 30 peer-reviewed scientific publications.
Mahidol Oxford Tropical Medicine Research Unit, Thailand
Adjunct Associate Professor Stuart Blacksell is an Australian with more than 27 years working experience in microbiology research activities who has been actively been involved in studies in Asia (Thailand, Laos, Cambodia, Vietnam, China) since 1989. He has been employed by the Nuffield Department of Clinical Medicine at the University of Oxford since August 2001 and is based at the Mahidol-Oxford Tropical Medicine Research Unit (MORU) in Bangkok, Thailand. From 1983-2001, prior to moving to the University of Oxford, he worked at the BSL-4 CSIRO Australian Animal Health Laboratory (AAHL) in Geelong, as well as the organization’s Thai and Lao-based projects. He holds Bachelor of Applied Science (Charles Sturt University), M.P.H., and Ph.D. degrees (both University of Queensland). He is also qualified as a Registered Biosafety Professional (RBP) by the American Biological Safety Association. He also holds adjunct associate professorships at the School of Population Health, University of Queensland and the School of Veterinary & Biomedical Science, Murdoch University in Australia and is an honorary research lecturer at the University of Oxford. He is a fellow of the Australian Society of Microbiology, fellow of the Australasian College of Tropical Medicine, and fellow of the Royal Society for Tropical Medicine and Hygiene. He has served as a member of the Asia-Pacific Biosafety Association (A-PBA) committee (2009/2010) and has lectured at A-PBA training courses. He has also been a committee member of the Biosafety and Biosecurity Network of Thailand (BSNT). In his position at MORU, he is the senior expatriate microbiologist and the head of biosafety and biocontainment. He has been responsible for the design, construction, and certification (Oxford and BMBL standards) as well as the management of the
new BSL-2 and BSL-3 laboratories in Bangkok and Laos that are essential for laboratory studies of scrub typhus, murine typhus, and melioidosis. He is also responsible for biological safety at MORU’s Thai, Lao, and Cambodian laboratories. Dr. Blacksell has authored or co-authored more than 70 scientific papers.
Robert Koch Institute, Germany
Dr. Reinhard Burger is the president of the Robert Koch Institute in Germany. He is the former head of both the Department for Immunology and the Department for Infectious Diseases. He received his Ph.D. (1976) and habilitation (1982) at the Institute for Medical Microbiology at the University of Mainz. From 1983-1987 he served as a professor for immunology at the Faculty for Theoretical Medicine at the University of Heidelberg. Since 1989 he has been a professor for immunology at the Free University of Berlin (University Hospital Benjamin Franklin). Dr. Burger was also a visiting scientist in various institutions abroad, such as the National Institutes of Health in Bethesda, MD, United States, and later at Harvard Medical School in Boston, and at the Medical University in Wuhan, China. He is a member of a number of scientific societies, including the German Society for Immunology, the German Society for Hygiene and Microbiology, the American Association of Immunologists, the German Society for Transfusion Medicine and Immune Hematology, and the American Association of Blood Banks. In 1993 Dr. Burger was appointed as chairman of the National Advisory Committee on Blood of the German Federal Ministry for Health. This national committee of experts gives advice to the federal government on all aspects of the safety and efficient use of blood components and plasma derivatives. Dr. Burger has many immunological publications, particularly concerning the detection of infectious agents and the safety of blood and blood products, and is a member of many national and international expert committees.
Beijing Institute of Biotechnology, China
Cheng Cao, Ph.D., graduated from the Department of Biology in Wuhan University and was awarded the Ph.D. degree from the Beijing Institute of Biotechnology. He finished his postdoctoral training at the Dana Farber Cancer Institute at Harvard Medical. Dr. Cao was then appointed to the position of professor at the Beijing Institute of Biotechnology. His work focuses on molecular cell biology and the diagnosis of viral diseases.
Chapman, Leonard (Will)
Defense Threat Reduction Agency (DTRA), United States
As the deputy program manager for the Cooperative Biological Engagement Program, Mr. Chapman is the lead for the program’s expansion activities as it moves out of the former Soviet Union. He has been a leader in the biological threat reduction field for the last five years and is active on several interagency and White House-level working groups. Mr. Chapman’s efforts have often focused on the question of sustainability of international biological capacity building efforts, and he has several publications on this work. He has worked in the threat reduction sphere for the past nine years with direct implementation experience in 15 countries.
Science Adviser, Arms Unit Legal Division, International Committee of the Red Cross, Switzerland
Neil has over ten years experience in research and policy work on international security issues. From 2007 to 2011 he was responsible for policy work on science and international security at the Royal Society, the U.K.'s national academy of science. There he focused on nuclear, biological, and chemical arms control, non-proliferation, and security issues, as well as the security impacts of developing science and technology such as neuroscience. He is author of ‘Non-Lethal’ Weapons, published by Palgrave Macmillan in 2009. Prior to joining the Royal Society, Neil was in the Department of Peace Studies at the University of Bradford for five years. There he was lead researcher on “non-lethal” weapons and contributed to work on chemical and biological arms control policy. In 2000 he completed training as a biological weapons inspector with the United Nations Monitoring, Verification and Inspection Commission.
Neil holds a B.S. in biology from University College London and a Ph.D. in peace studies from the University of Bradford.
Academy of Military Medical Sciences, China
Tianxi Diao holds a Ph.D. in preventive medicine. He is a professor at the Academy of Military Medical Science. His current research field is policy and strategy for technology development for preventive medicine.
Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russia
Dr. Dzagurova holds an M.D. and Ph.D. in virology. She is the head of the Laboratory of Hemorrhagic Fevers at the Chumakov Institute of Poliomyelitis and Viral Encephalitides at the Russian Academy Medical Sciences. She has been in this position since 2006. She attended the Medical Institute of Vladikavkaz (Russia), Licentiate in 1973. From 1973-1977 she was a post-graduate student, then a junior researcher, senior researcher, and lead researcher at the Laboratory of Hemorrhagic Fevers, Institute of Poliomyelitis and Viral Encephalitides (USSR Academy of Medical Science, Moscow, USSR). Her research interests include virology, laboratory diagnosis, vaccines, and hantaviruses. In particular, she has studied the ecology and biology of hantaviruses, the epidemiology of hantaviral infections, hantavirus vaccination, and methods for laboratory diagnosis of hantavirus infections.
El Harrak, Mehdi
Biopharma Lab, Morocco
Mehdi El Harrak, D.V.M., Ph.D., has been the technical manager of Biopharma, the national reference laboratory for veterinary diagnostic and vaccine production in Morocco since 2005. He was the head of the Virology Department at Biopharma from 1985 to 2005 and has been the secretary general of the Laboratory Commission at the World Organization of Animal Health (OIE) since 2006. Dr. El Harrak is also a consultant for the United Nations Food and Agriculture Organization (FAO) and the World Bank.
El Ouni, Naceur
Institute Pasteur of Tunis, Tunisia
Dr. El Ouni holds a degree in industrial engineering from the National Engineers School of Tunis (1986). He is currently engineer-in-chief at the Institute Pasteur of Tunis, Tunisia (IPT). He began at the IPT in 1987 as a technical engineer and has served IPT in many different roles ever since. He became a member of the Board of Directors of IPT in 1999, was a project manager for the construction and design of a new good manufacturing practices (GMP) production unit for vaccines and serums (2000), and recently became the deputy director of studies and shared services (including safety services). Dr. El Ouni has a wide range of technical skills in the following areas: analysis and biomedical research equipment, industrial pharmaceutical processes, water treatment and purification, and air handling. In 2010, he provided technical assistance for a French-Tunisian biotechnology project on vaccine production. In 2006, he worked on the design and installation of a P2+ laboratory for the research department of the National School of Veterinary Medicine, Sidi Thabet, Tunis. In 2000, he designed a sera purification process chain. He also supervised the technical component of the vaccine production unit’s renovation project at the Institute Pasteur of Tunis (IPT) and has worked abroad on many projects.
United States Naval Medical Research Unit #3, Egypt
Dr. Elyan has close to 25 years of lab experience in the field of virology and is an expert in handling highly infectious materials in P3 enhanced and P3+ conditions and in preparing diagnostic reagents. He also has been engaged with outbreak investigation and control and has worked with select agents in BSL-3 and BSL-4 facilities. He has lead biosafety decontamination teams for 10 years. Currently, Dr.
Elyan is a special assistant to the head of the cooperative biological engagement program at United States Naval Medical Research Unit No. 3 (NAMRU-3). He holds dual appointments as NAMRU-3’s country manager for Pakistan and as the capacity building and enhancement coordinator for Afghanistan and is experienced in medical diplomacy. Dr. Elyan implements total quality (TQ) systems, quality control & quality assurance (QC&QA), and good laboratory practices (GLPs) with a special focus on safety, biosurety, and biosecurity strategies. As a senior researcher, Dr. Elyan also conducts trainings and workshops for local and international trainees and medical researchers. Much of his work takes place in conflict areas where security and safety are of the highest concern.
Veterinary Serum & Vaccine Research Institute, Egypt
Since 2010, Seham Abd El-Rasheed Sayed El-Zeedy has served as director of the Veterinary Serum and Vaccine Research Institute (VSVRI). VSVRI was established in 1903 on an area of about 23 square hectares in the Abassia district, East Cairo. The main goals of VSVRI are to produce the highly efficient viral vaccines, bacterial vaccines, diagnostic biological reagents, and antisera needed to immunize farm animals, poultry, and companion animals against infectious diseases prevalent in Egypt and exotic diseases introduced to the country. VSVRI produces about 72 products and contains 14 research departments: five departments for bacterial vaccines, eight departments for viral vaccines, and a genetic engineering research department.
Koç University, School of Medicine, Turkey
Onder Ergonul is a professor of infectious diseases at Koç University, School of Medicine in Istanbul, Turkey. He graduated from Hacettepe University School of Medicine in 1989 and completed his residency in 1996 in the Infectious Diseases and Clinical Microbiology Department of Ankara University in Ankara, Turkey. He received a M.P.H. degree from Harvard University School of Public Health in 2003. In 2000-2002, he worked as a research fellow in the Clinical Epidemiology Division of the Infectious Diseases Department at the University of Utah, School of Medicine, United States. He is a member of the steering committee of the EU-FP7 project “International Network for Capacity Building for the Control of Emerging Viral Vector Borne Zoonotic Diseases,” and a partner of the European Research Infrastructure on Highly Pathogenic Agents project. He received the Public Health Scientific award from the Turkish Medical Association in 2007. He is the program director of the research methodology course of Koç University, School of Medicine in collaboration with Harvard Medical School and the Istanbul branch of the Ministry of Health.
Marmara University, Turkey
Aysen Gargili is currently a professor at the Marmara University Infectious Diseases Epidemiology Research Center (MEHAM). She graduated from Istanbul University’s Veterinary Faculty in 1989 and completed her doctorate in 1995 at the Institute of Health Sciences, Istanbul University. Prior to joining MEHAM, she was a lecturer at Istanbul University’s Veterinary Faculty (1995-2001) and Istanbul University’s Cerrahpasa Medical School (2001-2007). She is currently responsible for directing research projects, teaching medical and-premedical students, and training graduate and post-graduate students. She works collaboratively with related staff of the Ministry of Agriculture and the Ministry of Health (MOH). She is a referee board member of The Scientific and Technological Research Council of Turkey (TUBITAK) and responsible for the scientific evaluation of national and international projects. She is a member of the Tick Surveillance Study Group at MOH, the Lyme Disease Study Group at MOH, and a counselor for the MOH Istanbul Branch. She has experience at Gifu University Medical School, Japan (1999) as a scientific trainee, the International Center for Genetic Engineering and Biotechnology, Malaria Department, New Delhi, India (2000) as a postdoctoral fellow, and the Ludwig Maximillien University, Tropical Diseases Institute, Molecular Parasitology Section, Munich, Germany (2005) as a visiting scientist. She has presented 14 talks as an invited speaker in international congresses and published 27 scientific papers in journals indexed in SCI/SCI expanded lists. She has conducted 4 national research
projects funded by TUBITAK and 2 international research projects funded by the EU FP6 framework in the last 5 years. She currently is involved with 2 international research projects. She has been employed by the WHO for the short term mission, Support for Molecular Diagnosis of CCHF, in Tajikistan in November 2009. She was a co-author on the WHO Health Impact Assessment of Climate Change in Turkey.
Gaytan, Marco Rico
SENASICA - CPA, Mexico
Marco Antonio Rico Gaytán has been with the Mexican-American Commission for Foot and Mouth Disease and other Exotic Diseases Prevention since 2003. He works in a BSL-3 laboratory performing serological diagnostic tests. In 2008, he was designated as a biosafety officer for the BSL-3 activities. He earned a veterinarian degree in 1997 from the Universidad Nacional Autonoma de Mexico (Mexico National University). From 1995-2002 he collaborated with several institutions and companies in the public and private sector doing activities such as teaching, investigation animal viral diseases, and performing animal disease diagnostic tests.
Jean-Paul Gonzalez graduated as a medical doctor from the Medical School of Bordeaux in 1974. After completing his internship in French Guyana, he spent most of his career out of France as a medical researcher. He received his Ph.D. in viral ecology in 1984 from the University of Clermont-Ferrand, in Auvergne, France. As a researcher at the Institute for Research for the Development (IRD, Paris) he dedicated his career to research and training in many developing countries throughout the Americas, Africa, and Asia. His main fields of research encompass several domains of viral disease epidemiology and virus ecology, including vector transmitted viral diseases, viral hemorrhagic fevers, emerging viral diseases and the study of domains of disease emergence. Since the late 70s, he has been leading international teams of researchers from his own institute and institution partners in developing countries. For a decade he led teams of virologists at the Dakar Pasteur Institute (Senegal) and also at the Bangui Pasteur Institute (Central African Republic). He has spent several years in the United States, working as a guest researcher at the CDC in Atlanta, Georgia and as a visiting professor of epidemiology and public health at Yale School of Medicine. In both institutions he was involved in high security laboratory practices and research and the initial development and application of geographical information systems in the field of health. For the past decade he acted as a visiting professor of microbiology at Mahidol University (Bangkok, Thailand), founded a research center for emerging viral diseases, and developed a multidisciplinary technical platform dedicated to research and training for vectors and vector borne diseases. With his group of researchers he identified several new pathogens for humans and animals and described new viruses, vectors, and hosts of diseases from different tropical domains. He contributed to developing tools and implementing strategies for the control and prevention of transmitted diseases. He and his team studied the spread and dynamics of several viral hemorrhagic fevers, adding spatial and temporal dimensions to a dynamic study of epidemiology. He also developed several scientific concepts including postulating that germs and hosts co-evolve on geologic time scales. He has more than 170 scientific papers in peer-reviewed journals. In September 2008, the Gabonese government appointed him the general director of the International Center for Medical Research in Franceville, Gabon.
World Organization for Animal Health (OIE), France
Keith Hamilton, B.V.Sc., M.Sc., M.R.C.V.S., is a veterinarian from the British Iles. Having worked in mixed animal practice, field disease control programs, and with an NGO in India, he went on to study infectious disease control at the London School of Hygiene and Tropical Medicine, including field work relating to the control of zoonotic African trypanosomiasis in Uganda. In 2003, he joined the U.K. government as an advisor on the control of veterinary exotic diseases and in 2007 was seconded to the World Organisation for Animal Health (OIE) where he works on a range of topics including laboratory capacity building, animal influenza, and biological threat reduction.
Institut Pasteur du Maroc, Morocco
Professor Mohammed Hassar is honorary director of the Institut Pasteur du Maroc (IPM) and emeritus professor at the Rabat School of Medicine and Pharmacy. He is an internist and a clinical pharmacologist. He served as director of the Institut National d’Hygiène from 1989 to 1993 and director of IPM from 2001 to 2010. Professor Hassar has been active in global public health for the past two decades. He serves on several WHO committees and panels and is also a board member of IANPHI (the Public Health Institutes of the World). His interests include capacity building in health research, rational drug use and drug safety, food and environmental safety, and biosafety.
Iyisan, A. Selma
Ministry of Agriculture, Pendik Veterinary Control and Research Institute, Turkey
Dr. Ayse Selma Iyisan graduated with a degree in Veterinary Faculty from the University of Istanbul in 1983 and started working at Pendik Veterinary Control and Research Institute (PVCRI) in 1984. From 1989-1992 she specialized in bacteriology at PVCRI. From 1985 to 1993, she was a Ph.D. candidate at the Department of Microbiology in Veterinary Faculty at the University of Istanbul. Since 1993, she has worked as the chief of the Laboratory in Serological Diagnosis and the Epidemiology and Statistics Unit at PVCRI. She became the Technical Deputy Director of the Institute in 2004. She obtained additional training at the Veterinary, Epidemiology, and Economic Research Unit of Reading University in the U.K. She has extensive experience with the development and implementation of control and epidemiological survey projects for livestock diseases such as avian influenza, brucellosis, and bovine spongiform encephalopathy. Dr. Iyisan has authored 20 publications.
Kazi, Birjees Mazhar
National Institute of Health (NIH), Islamabad, Pakistan
Dr. Birjees Mazher Kazi is working as executive director at the National Institute of Health (NIH), Islamabad, Pakistan. He is a pathologist, hematologist, and public health laboratory specialist. He is also the chief of Public Health Laboratories, Division of NIH, which is a WHO collaborating centrer for research and training in viral diagnostics. Dr. Kazi is the national technical coordinator and a faculty member of the Field Epidemiology and Laboratory Training Program, CDC-NIH, Pakistan. He is a member of the Advisory Board of Directors of the Training Program for Epidemiology and Public Health Interventions, United States. Dr Kazi is the principal investigator of NIH-CDC’s National Lab-based Influenza Surveillance Project. Dr. Birjees Kazi is a medical graduate and joined NIH Islamabad Pakistan after completing a postgraduate diploma in clinical pathology. He underwent postgraduate training at Manchester Royal Infirmary, Manchester University as a WHO fellow. Later on, he earned a M. Phil. He is a fellow of the Pakistan College of Pathologists. Dr. Kazi is a member of the WHO Expert Advisory Panel on Health Laboratory Services. He introduced HIV and hepatitis B and C blood screening in public sector blood banks in Pakistan during 1995. Dr. Kazi played a leading role in the development of federal and provincial legislation on blood safety, HIV/AIDS, and the public health laboratory network. He also worked as principal investigator of WHO Tropical Diseases Research Program projects on leishmaniasis and bacterial meningitis. Dr. Kazi has written 87 scientific papers and compiled 4 national guidelines including the National Standards and Guidelines for Blood Transfusion Services of Pakistan and National Guidelines on Quality Assurance in Laboratory Medicine.
Pakistan Biological Safety Association and Aga Khan University Hospital
Erum Kahn is an associate professor in the Department of Pathology & Microbiology at Aga Khan University in Karachi, Pakistan and the president of the Pakistan Biological Safety Association. She also acts as the head of clinical microbiology in the Department of Pathology and Microbiology and is a
consultant clinical microbiologist in the Clinical Microbiology Laboratory at Aga Khan University Hospital. Additionally, Dr. Kahn is a visiting lecturer at the College of Physicians and Surgeons Pakistan and serves as co-chair of the academic program of IFBA. Dr. Kahn attended Dow Medical College (Pakistan), where she received her M.B.B.S. in medicine; Imperial College (London, U.K.), where she received her M.S. in molecular biology and pathogenesis of viruses; and the Royal College of Pathologists (London, U.K.); and the Fellow College of Physicians and Surgeons (Pakistan), where she studied medical microbiology. She is a member of the editorial boards for both the Journal of Microbiology and Biology Education and the Journal of Applied Biosafety. She is also a member of the national task force for national biosafety activities in Pakistan. Dr. Kahn has received numerous awards and grants and has participated in many biosafety activities at the local, national, and international levels. She has over 75 peer-reviewed publications.
Public Health Agency of Canada
Gary Kobinger obtained his Ph.D. with honors from the University of Montreal in 1998 before completing a post-doctoral fellowship at the University of Pennsylvania. In March 2005, Gary was recruited by the National Microbiology Laboratory in Canada where he is the chief of the Special Pathogens Program and has an adjunct professor appointment at the University of Manitoba. Gary was granted several awards including the 2010 Research Merit Award from Public Health Canada. He currently holds funding from several agencies and has been elected by WHO to serve as co-director of the WHO Collaborating Centre for Emerging and Zoonotic Diseases Detection, Diagnostics, Reference and Research and to co-chair the Emerging and Dangerous Pathogens Laboratory Global Network for Outbreak Response and Readiness.
Abdi Ibrahim Pharmaceuticals, Turkey
Seval Korkmaz is a cell culture and in vitro screening supervisor at Abdi Ibrahim Pharmaceuticals Inc. in Istanbul, Turkey. During the first years of her scientific career (1996-2006), Dr. Korkmaz was a researcher and assistant professor at the Pharmacology Department of Anadolu University and the Faculty of Pharmacy. She later established the first cell culture laboratory in the Turkish pharmaceutical industry in 2006 at FARGEM Inc. to allow permeability studies of generic drugs. She has been working at Abdi Ibrahim Pharmaceuticals since March 2010 where she has just established the second cell culture laboratory in the Turkish pharmaceutical industry. While most of her university studies were on high-throughput screening of natural and synthesized substances, recently she has worked on permeability studies, in vitro high-throughput studies of drugs and drug candidates, and models of biological barriers. She just developed and is seeking to patent a new in vitro blood-brain barrier model that is 2-fold more successful than the best currently available blood-brain barrier models.
Spiez Laboratory, Switzerland
Daniel Kümin studied microbiology at the University of Berne in Switzerland before moving to the Ecole Supérieure de Biotechnologie de Strasbourg in France, where he obtained his master’s degree in biotechnology, specializing in molecular biology (1999). For his master’s thesis, he studied the tropism of porcine adenoviruses looking for ways to improve the vector potential of these viruses. This work was done at the Australian Animal Health Laboratory (AAHL) in Geelong, Australia. His Ph.D. project on the biology and vector potential of ovine adenoviruses was performed at a private biotechnology company in Berlin, Germany. He received his Ph.D. from Humboldt University in Berlin, Germany in 2003. He then returned to Switzerland for his post-doc, working at the Institute of Veterinary Virology of the University of Berne. In 2007 he left research and joined the Federal Office for the Environment where he was responsible for, among other things, the development of a national biosafety curriculum and was also involved in the review of notifications and permits for work with genetically modified and pathogenic organisms according to the Containment Ordinance. In 2008 he was offered the Biosafety Officer (BSO) position at Spiez Laboratory. Spiez Laboratory is the national center of competence for nuclear, biological, and chemical protection. Spiez Laboratory is currently constructing a new high-containment
facility, the first of its kind in Switzerland. Daniel Kümin has been involved in biosafety training for a number of years, nationally as well as internationally. He has collaborated with WHO providing expertise in biosafety training for several courses.
Taras Shevchenko National University of Kyiv, Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine (NASU)
Olena Kysil, who has a Ph.D. in biology (2004), is an advanced doctoral level student and assistant professor at National Taras Shevchenko University of Kyiv and a researcher at the Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine. She has a strong background in the life sciences and practical training in the political sciences having served an internship in the Parliament of Ukraine. A biologist by training, her current research interest is Ukraine’s biosafety and biosecurity system. Since October 2008, as an assistant to the chairman of the Commission on Biosafety and Biosecurity of the National Security and Defense Council of Ukraine, she has been directly involved in generating analysis and recommendations that will guide the development of the national strategy on biosafety, biosecurity, biopreparedness, and public health.
Lee, Soh Jin
International Vaccine Institute, South Korea
Soh Jin Lee holds a M.S. in medical laboratory science from Inje University and is a special research student at Kyoto University in Japan with a scholarship from Ministry of Environment, Japan. She joined the International Vaccine Institute (IVI) as general manager of the ABSL-3/BSL-3 in March 2010. Prior to appointment at IVI, she worked for GreenCross Vaccine in Korea and RheinBiotech in the Netherlands. She also performed regulatory affairs and WHO prequalification consulting for vaccines at Innopath International Inc. After that, she moved to the biosafety field by transferring to Institut Pasteur Korea in 2005. As a biosafety officer, Ms. Lee obtained the first BSL-3 certificate in Korea. Based on her experience, she was asked to participate in the construction of a new building that included BSL-3 facilities and obtained the second certificate for it. After moving to IVI, she made the systematic changes necessary to obtain a BSL-3 certificate for the facility. She’s been developing a BSL-3 manual, standard operating procedures, user protection systems, and several kinds of biosafety training programs, including ABSL-3/BSL-3 training. She received her biosafety and biosecurity training from Institut Pastuer-Paris, Institut Pastuer-Shanghai, the National Institute of Infections Diseases (Japan), the Korean Centers for Disease Control and Prevention (KCDC), the Korean Biological Safety Association, and A-PBA. Ms. Lee was a member of the Biosafety Advisory Committee, KCDC and has been invited to speak to several government agencies and at international workshops.
London School of Economics, U.K.
Filippa Lentzos is a senior research fellow in the BIOS Centre at the London School of Economics. Originally trained in human sciences before switching to sociology, she focuses on social, political, economic and legal questions in the fields of biosecurity and synthetic biology.
Ling, Ai Ee
Singapore General Hospital/Singapore Health Services
Dr. Ling Ai Ee currently chairs the SingHealth IBC (Institutional Biosafety Committee), which provides advice and guidance for all institutional biosafety committees of the constituent health institutes in the SingHealth group, which includes Singapore General Hospital, KK Women’s and Children’s Hospital, five National Specialist Centers, and the SingHealth Experimental Medical Center. The SingHealth IBC also appoints an expert panel to review all research protocols relating to biological agents and toxins pursuant to the Biological Agents and Toxins Act, 2005. She also is director of the Office of Safety Network, Singapore General Hospital, which provides oversight of all safety issues in research laboratories in the SingHealth group and is directly involved in all safety issues in Singapore General Hospital. A committee
member of the National Biosafety Committee, Ministry of Health, Singapore, she also sits on two of its subcommittees: the Select Agents Technical Working Group and the Training Technical Working Group (co-chair). In addition, she is a committee member of the Genetic Modification Committee (GMAC), Singapore.
WRAIR, United States
Colonel Arthur Lyons holds a B.S. degree from the College of William and Mary, United States (1985), a Ph.D. degree in organic chemistry from the University of Iowa, USA (1991), and an M.D. from the University of Iowa, USA (1995). He is board-certified in internal medicine (2000, 2009) and infectious diseases (2001, 2010). Colonel Lyons is a military research physician with 16 years of active duty military service developing therapeutics, prophylactics, diagnostic devices, surveillance and laboratory systems against infectious disease threats of military and global health importance, especially flaviviruses (Japanese encephalitis and dengue), adenovirus, influenza, and other pathogens of regional and global public health importance. He is a subject matter expert on Japanese encephalitis, adenovirus vaccine development, and operational medicine. He establishes national and international research collaborations with United States federal agencies, non-governmental organizations, international Ministries of Public Health, biotechnology firms, management consulting firms, and leading universities. Additionally, he initiates and leads basic, clinical, and field medical research in the United States, Europe, Asia, and Africa in accordance with local IRB, United States Food and Drug Administration, and host nation guidelines. Colonel Lyons publishes work in peer-reviewed scientific journals and represents the United States Army Medical Research and Materiel Command at national and international scientific and policy meetings. He is an attending physician at Walter Reed Army Medical Center and National Naval Medical Center. Colonel Lyons is also an assistant professor of medicine at Uniformed Services University of the Health Sciences responsible for teaching medical students. He is currently the director of United States/Georgia Laboratory Operations, which is responsible for a primary mission to develop a new Department of Defense laboratory in the country of Georgia.
Leila dos Santos Macedo has been a senior researcher on biosafety at the Oswaldo Cruz Foundation in Brazil since 1982. She holds a Ph.D. in microbiology and immunology. She established the quality control system of human vaccines in Brazil from 1983 to 1988 and established the Biosafety Program at the Ministry of Health in Brazil from 1988-1994. She was chair of the National Biosafety Committee at the Ministry of Science and Technology from 1996-1998. Dr. Macedo founded the Brazilian Biosafety Association (ANBio) in 1999, and she has been its president since that time.
University Hospital for Infectious Disease, Croatia
Dr. Alemka Markotic is an associate professor and lecturer in postgraduate studies at the medical school of the University of Rijeka and she teaches at medical schools in Zagreb, Osijek and Split, Croatia. She is also head of the Research Department and head of the Department for Clinical Immunology, University Hospital for Infectious Diseases (UHID) in Zagreb, Croatia. She received her M.D. at the University of Sarajevo, Bosnia and Herzegovina (1989), an M.S. in medical microbiology and parasitology (1996), and a Ph.D. in infectious diseases (1999) from the University of Zagreb Medical School. Dr. Markotic began her biomedical research career at the University of Sarajevo Medical School in Bosnia and Herzegovina studying ribavirin treatment of hantaviruses during which time she collaborated with the United States Army Medical Research Institute for Infectious Diseases (USAMRIID) in Frederick, Maryland. She later received a National Academy of Sciences, National Research Council Postdoctoral Fellowship at USAMRIID to conduct research on the immunopathogenesis of hantaviruses. Based on this work she received the Joel Dalrymple Memorial Award (American Society of Virology) and the USAMRIID Coin. Dr. Markotic’s research on hantaviruses has earned her seven national and nine international awards. She has published 56 peer-reviewed papers and delivered over 90 presentations at national and international
conferences. She has been the principal investigator on research projects studying immune responses to intracellular pathogens, zoonoses, and apoptosis in hantavirus-infected 293HEK cells. At the UHID, Dr. Markotic established the Center for Emerging and Re-emerging Infection Diseases with nine international and six national partners, and she is responsible for managing the first Croatian BSL-2+ and BSL-3 laboratory that recently was completed at the UHID. She is trained and certified for work in BSL-3 facilities and received training in BSL-4 level work at USAMRIID. At the request of the EU Commission, Dr Markotic designed, organized, and presented a biosafety/biosecurity training workshop in Beijing, China in May 2009. She worked for several years at the Institute of Immunology in Zagreb as a head of the Viral Vaccines and Interferon Quality Control Unit. She is a member of the Council of the International Society for Hantaviruses, the Board for Allergy and Clinical Immunology at the Croatian Academy of Science and Arts, and was a member of the Committee of the Croatian Science Foundation, the National Council for Science, and vice-president of the Scientific Council in the Scope of Biomedicine and Health. In 2004, 2005, and 2009 she was an expert evaluator for FP6 projects (EU Commission, Brussels) in immunology and emerging infectious diseases. In the 1990s, during the war in Bosnia and Herzegovina, she helped organize the “Caritas” Pharmacy and Health Care Unit that addressed the health needs of those affected by the conflict.
Defense Threat Reduction Agency, United States
Michelle McKinney is the biorisk lead for the United States Defense Threat Reduction Agency’s (DTRA) Cooperative Biological Engagement Program supporting partners around the world in the sustainable implementation of risk-based laboratory biosafety and biosecurity practices. She has also served as a principal member of the technical staff in the International Biological Threat Reduction Program (IBTR) at Sandia National Laboratories. Prior to joining the IBTR, she was a principal life scientist with SAIC supporting a variety of customers regarding biorisk issues, most recently DTRA’s international cooperative threat reduction program. While at SAIC she also served as the safety and biosecurity manager for the National Bioforensic Analysis Center. Previously, Michelle was a research scientist at the United States Medical Research Institute of Infectious Diseases where she conducted novel research on molecular diagnostics of select agents and also has experience working in a variety of university and private industry settings researching infectious diseases. She received her B.S. in cellular and molecular biology from Tulane University and her M.S. in microbiology from Clemson University. Michelle has been a Certified Biological Safety Professional and Specialist Microbiologist in Biological Safety Microbiology, National Registry of Certified Microbiologists since 2000. She is an active member of ABSA having served as an instructor, committee chair, and team leader. She is currently a member of the ABSA Council and was recently appointed co-chair of the Biosafety Professional Accreditation Working Group with the International Federation of Biosafety Associations.
Melboucy, Mohamed Abdeldjallil
Pasteur Institute of Algeria
Mohamed Abdeldjallil Melboucy is currently in charge of quality assurance and biosafety at the Pasteur Institute of Algeria. He has a diploma in public health quality and risk management from the Lille Institute of Health Engineering. He has worked in both the pharmaceutical and hospital fields. He is experienced in implementing Good Manufacturing Practices (GMP) for safety and hygiene, pharmaceutical production, analytical chemistry, and controlled atmosphere processes. He has developed protocols for assessing the performance of mobile decontamination techniques for air contaminated with Aspergillus and other microorganisms.
Institute for Animal Health, U.K.
Dr. Uwe Mueller-Doblies studied veterinary medicine at the Free University of Berlin and virology and immunology at the University of Cambridge, U.K. He received a doctorate in veterinary virology from the University of Zurich, where he also completed a postdoctorate degree in parasitology. With a fellowship from the Swiss Science Foundation he joined the Microbial Pathogenesis Center at the University of
Connecticut studying the immunology of pathogen transmission by hard ticks. In 2003, Dr. Mueller-Doblies was appointed as head of biosecurity and named veterinary surgeon for the Institute for Animal Health at the Pirbright Laboratory. He is a diplomat of the European College for Veterinary Public Health and chairman of the International Veterinary Biosafety Workgroup. At the Pirbright Laboratory, Dr. Mueller-Doblies interacts closely with research groups and reference laboratories working in the high-containment facilities. In his current role, he participated in the working group of the Advisory Committee for Dangerous Pathogens to develop the guidance for the deliberate work with biological agents in the U.K., participated in the EU foot and mouth disease (FMD) working group to revise the EU minimum standards for laboratories working with FMD virus, worked for the EU Food and Veterinary Office as a national expert on numerous missions to inspect veterinary high-containment facilities, and served as an external member on the National Bio and Agro-Defense Facility design review team for the United States government. Aside from managing the biocontainment aspects of the IAH Pirbright Laboratory, Uwe specialized in technical risk assessments of biocontainment facilities and maintains a strong interest in vector-borne diseases.
Novosibirsk State University, Russia
Sergey V. Netesov, Ph.D., D.Sci. (1953) has been vice rector (research) of the Novosibirsk State University since November, 2007 and is also head of the university’s Bionanotechnology Laboratory. Prior to this position, he served for 30 years at the State Research Center of Virology and Biotechnology (“Vector”) becoming deputy director in 1990. He graduated from Novosibirsk State University and joined Vector in 1977. He later received a Ph.D. (1983) and a Doctor of Biology degree (1993). He is a member of the Russian Biotechnology Association; the American Society for Virology; the Russian Society of Epidemiologists, Microbiologists, and Parasitologists; the American Society for Virology; AAAS; the American Biosafety Association; the European Biosafety Association; and the Filovirus Study Group of the International Committee on Taxonomy of Viruses. He is a corresponding member of the Russian Academy of Sciences (since 1997) and the European Academy of Sciences (since 2004). In the beginning of his research career, he developed original methods for isolating restriction endonucleases and reverse transcriptases. Later, Dr. Netesov headed Russian projects that sequenced the genomes of the Marburg, Ebola, Venezuelan equine encephalitis (VEE) virus, and Eastern and Western equine encephalitis viruses. He was a leader of the reverse genetics project on the VEE virus reconstruction from cDNA fragments. He also led the work on sequencing Russian strains of tick-borne encephalitis and influenza viruses and was involved in the development of an inactivated vaccine for hepatitis A. Recently, he completed projects focused on the molecular diversity and epidemiology of viral hepatitis in Siberia and currently participates in other molecular epidemiological and biotechnological projects. He, together with his colleagues, received two Russian government awards (1998 and 2006) for the development and production of modern ELISA diagnostic kits against viral hepatitis and HIV and for development of bioterrorism prevention measures in Russia. His research interests include virology and biotechnology. Dr. Netesov has more than 140 publications in Russian and international scientific journals and 12 patents.
Öktem, Hüseyin Avni
Middle East Technical University, Turkey
Professor Öktem got his B.Sc. (biological sciences) and M.Sc. (biochemistry) degrees from Middle East Technical University (METU) in Ankara, Turkey, followed by a neurochemistry certificate and Ph.D. in biochemistry from Josef Attila University in Hungary (1990). He worked for a year at the Plant Biotechnology Institute of Texas Tech University. He established one of the first plant genetic transformation research facilities in Turkey, and at 36 years old he became a full professor of biochemistry at METU. He was involved in more than 100 academic and industrial research and development (R&D) projects as either project director or researcher. He has more than 50 scientific publications and 6 utility models/patents (1 pending patent) applications. Dr. Öktem acts as a referee and consultant for various governmental and private organizations, and he is the chairman of the Turkish Biotechnology Association. Professor Öktem is the co-founder and owner of two technology companies: OBiTEK-Middle East United Technologies Ltd. Co. and NANObiz NanoBioTechnological Systems R&D
and Consultancy Ltd. Co. Currently, he holds a full professor position in the Molecular Biology and Genetics Department of Middle East Technical University. He is responsible for strategic planning and R&D operations at NANObiz Ltd. Co. His fields of expertise include biosensing technologies, homeland security, molecular diagnostic, array technologies, biosensors, and transgenic plant technology.
Paranjape, Suman (Sumi)
Department of State, United States
Dr. Sumi Paranjape is an American Association for the Advancement of Sciences (AAAS) Fellow and a program officer at the Bioengagement Program (BEP) of the United States Department of State. Sumi currently manages the India and Pakistan portfolios for BEP and leads efforts for several international collaborations with the World Health Organization and the European Committee for Standardization. Sumi is the focal point for the Department of State’s efforts on United States initiatives on the International Health Regulations and laboratory capacity. Before beginning at the State Department, Sumi performed research spanning the areas of infectious diseases, biochemistry, molecular biology, and public health. As a President’s Postdoctoral Fellow at the University of California, Berkeley, Sumi studied dengue virus and collaborated with scientists at the Nicaragua Ministry of Health to increase dengue and West Nile virus diagnostic and surveillance capacity. Sumi earned her Ph.D. in biomedical sciences from the University of California, San Diego and a M.P.H. from the University of California, Berkeley.
Indian Council of Agricultural Research (ICAR), Krishi Bhawan, New Delhi, India
Dr. Gaya Prasad obtained a bachelor of veterinary sciences and animal husbandry (1977), a master’s in veterinary sciences (microbiology) (1980), and a Ph.D. in microbiology and public health (1984) from G.B. Pant University of Agriculture & Technology in Pantnagar, India. He worked as a postdoctoral fellow (1986-1988) at M.D. Anderson Hospital and Cancer Institute at the University of Texas, Science Park Research Division in Smithville, United States. He started his career as a teaching associate at G.B. Pant University of Agriculture & Technology in 1982 and became an assistant scientist in 1983 at Chaudhary Charan Singh Haryana Agricultural University, Hisar. Dr. Prasad became a scientist and associate professor in 1995 and professor and head of the Department of Animal Biotechnology in 2003. Dr. Prasad became the assistant director general (animal health) of ICAR at Krishi Bhawan, New Delhi in July 2010. Dr. Prasad is a distinguished veterinary microbiologist and has made significant contributions in the fields of animal rotaviruses and bluetongue virus epidemiology and diagnostics. Dr. Prasad was also founder and head of the Department of Animal Biotechnology at Haryana Agricultural University. He served as principal investigator and co-principal investigator of several projects funded by ICAR, USAID, the United States Department of Fish and Wildlife Service, and the Ministry of Environment and Forests. He has published over 100 research papers in national and international journals and written several book chapters, laboratory manuals, conference proceedings, and books. He has been a keynote and invited speaker in several national and international conferences, symposia, and seminars and has received many awards. Dr. Prasad has served as the volume editor of the international review series “Progress in Vaccinology,” editor of the Indian Journal of Microbiology, managing editor of the Indian Journal of Virology, and president of the Association of Microbiologists of India. Dr. Prasad has been awarded fellowships from the National Academy of Agricultural Sciences, the National Academy of Veterinary Sciences, and the Association of Microbiologists of India.
Koç University, Turkey
Professor Ruacan graduated from Hacettepe University Faculty of Medicine in Ankara in 1969. He then completed postgraduate studies at the University of Pennsylvania and New York University. He later served as the dean of the Medical School and director of the Institute of Oncology at Hacettepe University. He was also a member of the Executive Board of the Turkish Scientific and Technical Research Council. Currently, he is the dean of Koç University Medical School, vice president of the Association of Asian Academies of Science, and a member of the Executive Council of the Interacademy Medical Panel. Professor Ruacan has been a member of the Turkish Academy of Sciences since 1994.
National Institute for Infectious Diseases, Japan
Dr. Masayuki Saijo is a medical doctor and received his Ph. D. degree in pediatrics under the directorship of Professor Yoshioka H. and Professor Okuno A. at Asahikawa Medical University in Japan (1991). His primary research field is viral infections. He has studied clinical infectious respiratory diseases in children and antiviral-resistant herpesvirus infections in immunocompromised subjects. He joined the National Institute of Infectious Diseases (NIID) in Tokyo, Japan in 1997 and has studied viral hemorrhagic fevers such as Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fevers as well as orthopoxvirus infections. He leads the Department of Virology 1 at NIID.
National Institute of Health Research & Development, Indonesia
Pretty Multihartina D. Sasono has been a researcher at the National Institute of Health Research and Development (NIHRD), Ministry of Health, Republic of Indonesia since 1989. She received her Ph.D. in biology from the University of Leeds, U.K. in 1997. She was part of the postdoctoral program at the Center for Biologic and Evaluation Research, United States Food and Drug Administration within the United States NIH Campus from 2008 to 2010. She was a project leader for building the BSL-3 laboratory at NIHRD from 2007 to 2008. Presently, she is a laboratory manager and the head of basic technology of the Health Division at the Center for Biomedical and Basic Technology of Health under the NIHRD.
State Researcher Centre of Virology & Biotechnology “Vector,” Russia
Dr. Shestopalov has served from 1991 to the present day as the director of the Division of Influenza and Zoonotic Infections at the Federal State Research Center of Virology and Biotechnology “Vector” in Koltsovo, Novosibirsk region (Russia) and also as a senior researcher at Novosibirsk State University. In 1979 he received an M.S. from Novosibirsk State University, Department of Natural Sciences, and in 1983 he received a Ph.D. from the Siberian Computer Center, Novosibirsk Specialization. In 1984 the Irkutsk Antiplague Institute gave him a certificate on work with especially dangerous infections. In 2005 he was at the World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds located at the Division of Virology Department of Infectious Diseases at St. Jude Children’s Research Hospital in Memphis, Tennessee, United States where he earned a certificate on work with influenza viruses. His research experience includes the study of epidemiology; virus and bacterial diseases dangerous to humans and animals; field epizotology and epidemiology; search, isolation, and identification of new strains of viruses and bacteria; research of immune pathogenesis of viral diseases; and development of medical, preventive and diagnostic preparations. His main research directions include immunopathogenesis of haemorrhagic fevers (Marburg, and CCHF), development of the means for haemorrhagic fever prophylaxis (Marburg, CCHF), and therapy (Marburg). Recent international projects led by Dr. Shestopalov include Russian flu surveillance from 2004-2010; the epidemiology of influenza A in wild birds, poultry and pigs in the Novosibirsk region, Siberia (2005-2006); monitoring of influenza A viruses in wild birds, poultry, and pigs in the Novosibirsk region (2007-2010); and measuring, monitoring, modeling, and predicting avian influenza in the Pacific Rim (2010-2012).
United States Centers for Disease Control and Prevention
Thomas M. Shinnick, Ph.D., is the associate director for global laboratory activities in the Division of Tuberculosis Elimination at the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention at the Centers for Disease Control and Prevention and an adjunct professor at the Department of Microbiology and Immunology at Emory University. He received a B.S. from the University of Wisconsin-Madison, a Ph.D. (biochemistry) from the Massachusetts Institute of Technology, and did postdoctoral training at the Research Institute of Scripps Clinic. His honors include the Johnson and Johnson Pre-
doctoral Fellowship (1977); Helen Hay Whitney Foundation Postdoctoral Fellowship (1978-1980); Arthur S. Flemming Award (1990); Fellow, American Academy of Microbiology (1994); and Senior Biomedical Research Service (1997). He has been chairman of Division U, American Society for Microbiology (1994); member of the National Tuberculosis Task Force; and member of the scientific advisory board for the Heiser Program. He is also co-chair of the Global Laboratory Initiative Working Group of the Stop TB Partnership, WHO Stop TB Working Group on Diagnostics, WHO Supranational Laboratory Network. Editorial activities include being the associate editor of International Journal of Tuberculosis and Lung Diseases and serving on the editorial board of Emerging Infectious Diseases, Tuberculosis, and Current Microbiology. Dr. Shinnick’s scientific interests include understanding the biology and genetics of the pathogenic mycobacteria, elucidating mechanisms of pathogenicity and drug resistance of Mycobacterium tuberculosis, developing rapid methods for the diagnosis of mycobacterial infections, and using genotyping to support TB control programs and elucidate the dynamics of transmission. He is the author/co-author of more than 150 publications and the editor of one book.
Chulalongkorn University, Thailand
Sunee Sirivichayakul works in the Department of Medicine, Faculty of Medicine at Chulalongkorn University in Bangkok, Thailand. She holds three degrees from Chulalongkorn University (B.S. in medical technology, M.S. in medical microbiology, Ph.D. in medical microbiology). Her current work is on molecular and immunologic studies of HIV (i.e., HIV genotypic drug resistance testing using in-house assays, pre-clinical development of HIV-1 DNA vaccines, development of low-cost viral load assays, and intracellular cytokine staining for immunologic evaluation of HIV-infected individuals).
CSIRO, Australian Animal Health Lab
Dr. Greg Smith is responsible for microbiological security at CSIRO’s Australian Animal Health Laboratory (AAHL) in Geelong, Victoria. Dr. Smith is the leader of the Microbiological Security Group at AAHL. He is currently the chair of the Institutional Biosafety Committee and the Security Sensitive Biological Agent Management Committee. AAHL includes high-containment BSL-3 and BSL-4 facilities to support its major role of diagnosing potential outbreaks of exotic (foreign) animal diseases and is a cornerstone of Australia’s emergency disease response capability. It is the only laboratory in Australia licensed by the Commonwealth Government for experimental work with exotic animal disease agents. Dr. Smith is responsible for ensuring exotic disease and other high risk agents are handled safely, that the building and laboratories are maintained and function according to specification, that staff are trained appropriately to operate without breaching microbiological security, and that AAHL is quarantine compliant. Dr. Smith has more than 30 years of experience in medical and veterinary virology, specializing in virus research and diagnostics. Prior to joining CSIRO in April 2009, Dr. Smith was the director of forensic and scientific operations at Queensland Health Forensic and Scientific Services in the Queensland Health Department. Dr. Smith commenced his career at the United States Army Medical Research Institute for Infectious Diseases at Fort Detrick, Maryland, in the early 1980s. He then spent 13 years as a molecular virologist with the Queensland Department of Primary Industries and Fisheries followed by 12 years with Queensland Health. At Queensland Health, he oversaw the construction of BSL-3 and BSL-4 facilities and managed the operation of those facilities for over a decade, which allowed him to acquire extensive knowledge of the operational and regulatory frameworks surrounding high-containment facilities. His academic qualifications include a B.A. degree from the University of Queensland in St. Lucia, Australia (1980), a M.S. in biomedical sciences from Hood College, Frederick, Maryland, United States (1985), and a Ph.D. in biochemistry from the University of Queensland in St. Lucia, Australia (1992). He is also currently a member of the National Association of Testing Authorities, a member of the American Biological Safety Association, and a member of the Association of Biosafety for Australia and New Zealand. Dr. Smith has published more than 75 peer reviewed scientific papers or book chapters on virology research and biocontainment topics.
Institute of Virology and Immunoprophylaxis (IVI), Switzerland
Kathrin Summermatter has been involved in biosafety for more than 15 years. Since 2002, she has been the head of biosafety and the deputy director at the Institute of Virology and Immunoprophylaxis (IVI), the Swiss reference lab for highly infectious animal diseases (ABSL-3). Specifically, IVI is responsible for the diagnosis, surveillance, and control of highly contagious epizootics such as avian influenza, foot-and-mouth disease, and classical swine fever. In addition, the IVI pursues research both on these viruses and emerging viral diseases, as well as their potential transmission to man. The IVI is also the competent authority issuing the licenses required for the sale of veterinary immunobiological products. In addition, Kathrin was the coordinator of BIOSAFETY-Europe. She has been a long-standing member of ABSA, the International Veterinary Biosafety Workgroup, EBSA, and was the president of EBSA in 2003/2004. Along with providing expertise and consultative services to both private companies and government institutions on matters of biosafety and biosecurity, containment issues, and safe operating procedures, she has given many lectures and taught courses to national and international audiences.
Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russia
Evgeniy Tkachenko, M.D. and Ph.D., is a professor of virology and epidemiology. Since 2006, he has been the deputy director of the Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy Medical Sciences and head of the Center on Hemorrhagic Fever with Renal Syndrome of the Russian Ministry of Public Health. He graduated from the Medical Institute of Moscow (Russia), Licentiate in 1965. Following graduation, he was a post-graduate student and later a junior researcher and senior researcher at the Laboratory of Hemorrhagic Fevers at the Institute of Poliomyelitis and Viral Encephalitides, USSR Academy of Medical Sciences (Moscow, USSR). In 1977, Dr. Tkachenko became the head of the Laboratory of Arenaviral Infections and in 1988 the head of the Laboratory of Hemorrhagic Fevers. His research interests include virology, epidemiology, laboratory diagnosis, vaccines, hantaviruses, and epidemiology.
Institute of Developmental Biology, Russian Academy of Sciences (RAS), Russia
Prof. Ugrumov graduated from Moscow University Medical School in 1970 and received a Ph.D. from the Institute of Evolutionary Physiology and Biochemistry, USSR Academy of Sciences in 1974. He was a senior researcher at the Institute of Human Morphology, Russian Academy of Medical Sciences (RAMS) (1974-77) and the Institute of Developmental Biology, RAS (1977-87). Prof. Ugrumov has been head of the laboratory at the Institute of Developmental Biology since 1987 and of the Institute of Normal Physiology since 1996. He got a professorship in pharmacology and radiobiology in 1996 at the State Medical University, Moscow, Russia and was elected as a corresponding member of the Russian Academy of Sciences in 1997 and as a full academician in 2006. Prof. Ugrumov is the advisor to the president of the RAS on international scientific cooperation, a member of the Scientific-technical Council of the chairman of the Federal Assembly of the Russian Federation, and vice president of the Russian Physiological Society. He was a visiting professor at the University Medical School, Tokushima (Japan) in 1988-89; the Medical University of Ulm (Germany) in 1993; the University of Tours (France) in 1998, 2000; and the University P. et M. Curie (Paris, France) in 1993-2010. His honors include the Orbeli Prize of the Russian Academy of Sciences in physiology (1995), a professorship from the Burroughs Wellcome Fund, and a prize from the Federation of American Societies for Experimental Biology (2001). His field of expertise is neurosciences, and his main studies are devoted to: (i) the development of neuroendocrine regulation in ontogenesis; (ii) the regulation of neurogenesis and differentiation by extracellular signals including morphogenetic factors; and (iii) the mechanisms of the brain plasticity and their regulation by signaling molecules in normal individuals and in neurodegenerative diseases (e.g., Parkinson’s disease).
Foreign Affairs and International Trade Canada
Ken Ugwu is the senior biocontainment specialist with Foreign Affairs and International Trade Canada working with the Global Partnership Program. Ken is an internationally recognized expert on engineering matters relating to the planning, design, construction, operation, and inspection of biocontainment facilities. Ken has over 25 years experience in this field and has been providing expert authoritative advice, training, and recommendations on these matters to professional scientific staff, engineering firms, and government decision makers in many parts of the world. Ken is a Registered Professional Engineer in the Province of Ontario, Canada. He is a member of the American Society of Heating Refrigeration and Air Conditioning Engineers, the American Biological Safety Association (ABSA), and the National Fire Protection Association and the co-chair of the Biocontainment Engineering Network of the International Federation of Biosafety Associations. Ken holds a B.A.Sc. in mechanical engineering from the University of Ottawa and a diploma in engineering management and industrial instrumentation.
van Doorn, H. Rogier
Oxford University, Vietnam
Rogier van Doorn is a Dutch clinical microbiologist who trained at the Academic Medical Center in Amsterdam, Netherlands. He works at the Oxford University Clinical Research Unit (OUCRU) in Ho Chi Minh City, Vietnam. Rogier did a Ph.D. on diagnostics and susceptibility of Mycobacterium tuberculosis, has worked and published on parasitology diagnostics, and currently heads the respiratory infections group at OUCRU. Rogier’s Ph.D. students work on antibiotic use in respiratory infections, respiratory syncytial virus, viral encephalitis, and H5N1 influenza. The virology lab at OUCRU is the reference virology lab of the Southeast Asian Infectious Disease Clinical Research Network and has recently started work in a newly built BSL-3/SAPO4 lab, funded by NIH and the Wellcome Trust, with labs for tuberculosis and animal and human virus work. Rogier was part of the team that supervised the design and realization of this lab and was responsible for the biosafety aspects during construction and certification.
Chulalongkorn University, Thailand
Supaporn Wacharapluesadee, Ph.D., is head of the Molecular Biology Laboratory for Neurological Diseases, King Chulalongkorn Memorial Hospital and the WHO Collaborating Centre for Research and Training on Viral Zoonoses, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. During 1994-1997, she worked on malaria research at the Department of Entomology, Armed Forces Research Institute of Medical Sciences. In 1997, she worked at Chulaporn Research Institute on cancer research. In 1998, she worked in the HIV research laboratory at the HIV/AIDS Collaboration Thai-USA. Since 2001, she has developed molecular techniques for detecting viral pathogens in clinical specimens, especially from encephalitis patients. Her particular areas of interest are viral encephalitis and emerging viral zoonoses carried by wildlife, especially bats and rodents. She holds an undergraduate degree in medical technology from Chiang Mai University, a master’s degree in biochemistry from Mahidol University, and a Ph.D. in biomedical sciences from Chulalongkorn University, Thailand.
Caribbean Med Labs Foundation, Trinidad & Tobago
Ms. Valerie Wilson is a trained immunologist and public health professional who has provided leadership and technical advisory services to Ministries of Health, private and public sector laboratories, and staff in 23 countries within the Caribbean region through her work at the Caribbean Epidemiology Centre, particularly in the areas of laboratory management, quality improvement, laboratory safety and strategic management. She has been involved in a leadership role in raising awareness of governments and laboratories in the Caribbean region with respect to the need for medical laboratory standards and quality
management systems including safety, has developed many training materials and approaches utilized within and external to the Caribbean, and has trained and mentored laboratory managers and supervisors within the region. Ms. Wilson is the director of a non-governmental organization, Caribbean Med Labs Foundation (CMLF), which is focused on strengthening laboratory services within the Caribbean region. CMLF has been successful in attracting funding under Round 9 of the Global Fund against HIV/AIDS as a sub-recipient under the Pan Caribbean Partnership against HIV/AIDS (PANCAP) grant and has recently begun to implement this five-year project for the strengthening of laboratory support for HIV/AIDS programs within the Caribbean region. CMLF is currently working with its Caribbean network of laboratory professionals and the International Federation of Biosafety Associations (IFBA) to establish a Caribbean Association for Biological Safety (CABSA) to promote and improve laboratory safety standards within the region.
National Institute of Health Islamabad, Pakistan
Syed Sohail Zahoor Zaidi is the head of the Department of Virology at the National Institute of Health, Pakistan. He is proficient in viral studies using classical as well as modern virological tools. He has been a focal person for many national as well as international public health projects like the WHO Polio Eradication Initiative, the WHO Measles Elimination Initiative, the United States CDC lab-based influenza project, and a number of national projects on rotavirus, dengue virus, Crimean-Congo hemorrhagic fever, hepatitis, and other diseases.
The National Academies, United States
Heather Chiarello joined the United States National Academy of Sciences in July 2008. She graduated magna cum laude from Central Michigan University in 2007 with a B.S. in political science with a concentration in public administration. Ms. Chiarello is currently a senior program assistant with the Ocean Studies Board in the Division on Earth and Life Sciences and the Committee on International Security and Arms Control in the Policy and Global Affairs Division of the National Academies. She is pursuing a master’s degree in sociology and public policy analysis at Catholic University of America in Washington, D.C.
The National Academies (Consultant), United States
Alison Hottes holds Ph.D. (2005) and M.S. (2000) degrees in electrical engineering from Stanford University and a B.S. (1998) in electrical engineering and mathematics from Utah State University. She just completed a postdoc at Princeton University where she developed experimental and computational methods to enable systems-level studies of bacteria. Her work, which spans the fields of genomics, bioinformatics, and microbiology, examines how mutations propagate through a bacterium’s cellular network, altering a range of phenotypes including antibiotic tolerance. She has authored peer-reviewed journal articles and a book chapter. In the winter of 2011, she was a Christine Mirzayan Science and Technology Policy Fellow at the United States National Academies and currently works as a consultant for the Committee on International Security and Arms Control of the United States National Academies.
The National Academies, United States
Benjamin Rusek works as a program officer for the Committee on International Security and Arms Control (CISAC) at the United States National Academy of Sciences (NAS) on issues related to nuclear and biological nonproliferation and arms control and the misuse of science and technology. Ben manages CISAC’s interaction with its counterpart in Beijing, China, CISAC’s programs examining threats related to biological weapons and dual use biotechnology, and serves as program staff on CISAC’s “Track II”
dialogues and CISAC-administered National Research Council (NRC) studies. Outside of the NAS, Ben is the chair of the executive board of International Student Young Pugwash (ISYP). Ben has political science degrees from The Ohio State University and Purdue University.
The National Academies, United States
Dr. Frances E. Sharples has served as the director of the National Academy of Sciences’ Board on Life Sciences since October 2000. Since spring of 2010, Dr. Sharples has also served as acting director of the Institute for Laboratory Animal Research. The Board on Life Sciences serves as the National Academies’ focal point for a wide range of technical and policy topics in the life sciences, including bioterrorism, genomics, biodiversity conservation, and key topics in basic biomedical research, such as stem cells. In 2003, Dr. Sharples directed a study on the organizational structure of the National Institutes of Health that led to the publication of the report Enhancing the Vitality of the National Institutes of Health: Organizational Change to Meet New Challenges, which resulted in major management and budgetary changes at NIH. In 2005, Dr. Sharples served as the study director for the preparation of the National Academies’ report Guidelines for Human Embryonic Stem Cell Research, which had a major impact on the oversight of stem cell research in the United States. Most recently she served as co-study director on the report Review of the Scientific Approaches Used During the FBI’s Investigation of the 2001 Anthrax Letters. Immediately prior to coming to the National Academies, Dr. Sharples was a senior policy analyst for the Environment Division of the White House Office of Science and Technology Policy (OSTP) from October 1996 to October 2000. Dr. Sharples came to OSTP from the Oak Ridge National Laboratory, where she served in various positions in research and management in the Environmental Sciences Division between 1978 and 1996. Dr. Sharples received her B.A. in biology from Barnard College (1972) and her M.A. (1974) and Ph.D. (1978) in zoology from the University of California, Davis. She served as an American Association for the Advancement of Science (AAAS) Environmental Science and Engineering Fellow at the Environmental Protection Agency during the summer of 1981, and served as a AAAS Congressional Science and Engineering Fellow in the office of Senator Al Gore in 1984-85. She was a member of the National Institutes of Health’s Recombinant DNA Advisory Committee in the mid-1980s and was elected a fellow of the AAAS in 1992.